Promise Bio
Epiproteomic Analyses on standard Mass-Spectrometry Data
Active
Seed
Startup
Tel Aviv-Yafo
Founded 2023-01
Promise Bio, a recent spin-out from the Weizmann Institute, is the first company to harness post-translational modifications (PTM) and artificial intelligence to reveal unique biological insights that are otherwise overlooked. Understanding immune-mediated diseases requires uncovering intricate proteomic patterns, and PTMs are the key to capturing the regul…
SectorHealth Tech & Life Sciences
StageSeed
Total raised$9.0M
Employees14
Founded2023-01
HQTel Aviv-Yafo
Confidence72
Sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technology
Artificial IntelligenceBiologicals
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals